Search results

Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events such as heart attacks or stroke after myocardial infarction (MI)

Type

Technology appraisal guidance

Published

14 December 2016

This guideline covers how to improve services for people aged 14 and above who have been diagnosed as having coexisting severe mental illness and substance misuse. The aim is to provide a range of coordinated services that address people’s wider health and social care needs, as well as other issues such as employment and housing.

Type

NICE guideline

Published

30 November 2016

Evidence-based recommendations on endoscopic transluminal pancreatic necrosectomy in adults. This involves removing dead tissue from the pancreas

Type

Interventional procedures guidance

Published

23 November 2016

Evidence-based recommendations on percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture in adults

Type

Interventional procedures guidance

Published

23 November 2016

Evidence-based recommendations on single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity

Type

Interventional procedures guidance

Published

23 November 2016

Evidence-based recommendations on dapagliflozin (Forxiga) in combination therapy for treating type 2 diabetes in adults

Type

Technology appraisal guidance

Last updated

23 November 2016

Evidence-based recommendations on apremilast (Otezla) for treating moderate to severe plaque psoriasis in adults

Type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults

Type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma in adults

Type

Technology appraisal guidance

Published

23 November 2016

This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.

Type

NICE guideline

Published

02 November 2016

Evidence-based recommendations on elbasvir–grazoprevir (Zepatier) for treating genotype 1 or 4 chronic hepatitis C (HCV) in adults

Type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating severe active rheumatoid arthritis in adults who have had a tumour necrosis factor

Type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on cobimetinib (Cotellic) with vemurafenib (Zelboraf) for unresectable or metastatic melanoma in adults with a BRAF V600

Type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on single-incision short sling mesh insertion for stress urinary incontinence in women

Type

Interventional procedures guidance

Published

12 October 2016

Evidence-based recommendations on miniature lens system implantation for advanced age-related macular degeneration. This involves implanting an artificial lens

Type

Interventional procedures guidance

Published

28 September 2016

Evidence-based recommendations on radium-223 dichloride (Xofigo) for treating hormone-relapsed prostate cancer with bone metastases

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on necitumumab (Portrazza) for treating locally advanced or metastatic epidermal growth factor receptor (EGFR)-expressing

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on talimogene laherparepvec (Imlygic) for treating unresectable metastatic melanoma in adults

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on aflibercept (Eylea) for treating visual impairment caused by macular oedema after branch retinal vein occlusion

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on pegaspargase (Oncaspar) for treating acute lymphoblastic leukaemia

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on secukinumab (Cosentyx) for treating active ankylosing spondylitis that has not responded well enough to conventional therapy

Type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on crizotinib (Xalkori) for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (NSCLC) in adults

Type

Technology appraisal guidance

Published

28 September 2016

This guideline covers children and young people who display harmful sexual behaviour, including those on remand or serving community or custodial sentences. It aims to ensure these problems don’t escalate and possibly lead to them being charged with a sexual offence. It also aims to ensure no-one is unnecessarily referred to specialist services.

Type

NICE guideline

Published

20 September 2016

This guideline covers preventing, assessing and managing mental health problems in people with learning disabilities in all settings (including health, social care, education, and forensic and criminal justice). It aims to improve assessment and support for mental health conditions, and help people with learning disabilities and their families and carers to be involved in their care.

Type

NICE guideline

Published

14 September 2016

This guideline covers the period before, during and after a person is admitted to, and discharged from, a mental health hospital. It aims to help people who use mental health services, and their families and carers, to have a better experience of transition by improving the way it’s planned and carried out.

Type

NICE guideline

Published

30 August 2016

Evidence-based recommendations on extracorporeal carbon dioxide removal for acute respiratory failure in adults. This involves reducing the level of carbon

Type

Interventional procedures guidance

Published

24 August 2016

Evidence-based recommendations on cabazitaxel (Jevtana) for prostate cancer that has come back after it was treated with docetaxel

Type

Technology appraisal guidance

Last updated

24 August 2016

Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for previously treated metastatic colorectal cancer in adults

Type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on degarelix (Firmagon) for advanced hormone-dependent prostate cancer in adults with spinal metastases

Type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on ramucirumab (Cyramza) for treating previously treated locally advanced or metastatic non-small-cell lung cancer

Type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had

Type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on bosutinib (Bosulif) for previously treated chronic myeloid leukaemia in adults

Type

Technology appraisal guidance

Published

24 August 2016

Evidence-based recommendations on percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation in adults. This involves destroying the

Type

Interventional procedures guidance

Published

27 July 2016

Evidence-based recommendations on abiraterone (Zytiga) for castration-resistant metastatic prostate cancer in adults who have had previous treatment with a

Type

Technology appraisal guidance

Last updated

27 July 2016

Evidence-based recommendations on abiraterone (Zytiga) for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated in adults

Type

Technology appraisal guidance

Last updated

27 July 2016

Evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) for treating advanced (unresectable or metastatic) melanoma in adults

Type

Technology appraisal guidance

Published

27 July 2016

Evidence-based recommendations on azacitidine (Vidaza) for treating acute myeloid leukaemia (AML) with more than 30% bone marrow blasts

Type

Technology appraisal guidance

Published

27 July 2016

Evidence-based recommendations on lumacaftor–ivacaftor (Orkambi) for treating cystic fibrosis in people 12 years and older who are homozygous for the F508del

Type

Technology appraisal guidance

Published

27 July 2016

This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.

Type

NICE guideline

Published

05 July 2016

Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting

Type

Interventional procedures guidance

Published

22 June 2016

Evidence-based recommendations on ultrasound-guided percutaneous radiofrequency ablation for treating benign thyroid nodules in adults

Type

Interventional procedures guidance

Published

22 June 2016

Evidence-based recommendations on microstructural scaffold (patch) insertion without autologous cell implantation for repairing symptomatic chondral knee

Type

Interventional procedures guidance

Published

22 June 2016

Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia (high cholesterol) and mixed dyslipidaemia

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on adalimumab (Humira) for treating moderate to severe hidradenitis suppurativa (HS) (acne inversa)

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on belimumab (Benlysta) as an add-on treatment for active autoantibody-positive systemic lupus erythematosus

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on trametinib (Mekinist) with dabrafenib (Tafinlar) for adults with unresectable or metastatic melanoma that has a BRAF V600

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on evolocumab (Repatha) for treating primary hypercholesterolaemia (high cholesterol) and mixed dyslipidaemia

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on ceritinib (Zykadia) for advanced anaplastic lymphoma kinase positive non-small-cell lung cancer...

Type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on biodegradable subacromial spacer insertion for rotator cuff tears. This involves using a balloon-like device to create a

Type

Interventional procedures guidance

Published

25 May 2016

Evidence-based recommendations on transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine in adults. This involves

Type

Interventional procedures guidance

Published

25 May 2016